Double digit drug price increases exceeding the rate of inflation have become the norm. According to the OneRx National Drug Index released earlier this year, in 2015 the cost of branded drugs was up by 14.77%; specialty drug prices jumped 9.21% and even generic drugs cost 2.93% more than the previous year.

However, pharmacy benefit managers are negotiating with suppliers and developing other strategies to help employers deliver more affordable drug benefits. EBA talked to Steve Miller, chief medical officer at Express Scripts to discuss the key drivers of growing drug costs and how the PBM is helping employers manage the escalating price of pharmaceuticals.

Register or login for access to this item and much more

All Employee Benefit Adviser content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access